By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BiondVax Pharmaceuticals 

Science Park, 14 Einstein Street
P.O. Box 4143
Ness Ziona    74140  Israel
Phone: 972-8-9302529 Fax: 972-8-9302531


Company News
BiondVax Pharmaceuticals Announces Third Quarter 2015 Financial Results And Update 11/9/2015 10:43:09 AM
BiondVax Pharmaceuticals Announces Upcoming Investor Events: Presenting At The LD Micro Conference In Los Angeles Following Investor Non-Deal Roadshow 11/5/2015 11:25:51 AM
BiondVax Pharmaceuticals Announces Successful Recruitment Of The First Participants In A Phase Ilb Clinical Trial In Europe With Its Universal Flu Vaccine: Multimeric M-001 10/21/2015 10:18:03 AM
BiondVax Pharmaceuticals To Present On October 8 At The Aegis Growth Conference 10/7/2015 10:06:29 AM
BiondVax Pharmaceuticals Establishes Capability For The Manufacture Of Clinical Grade Universal Flu Vaccine For Phase III Clinical Trials 10/1/2015 10:11:15 AM
BiondVax Pharmaceuticals Initiates A Phase Ilb Clinical Trial In Europe For Its Universal Flu Vaccine For Pandemic Outbreak 9/30/2015 7:26:26 AM
BiondVax Pharmaceuticals To Present On September 10 At The Rodman & Renshaw Global Investment Conference 9/8/2015 10:00:34 AM
BiondVax Pharmaceuticals Announces Intent To Launch A Phase 2 Trial In The United States In Collaboration With The U.S. NIH 9/2/2015 7:04:53 AM
BiondVax Pharmaceuticals Announces Second Quarter 2015 Financial Results And Update 8/24/2015 6:38:36 AM
Independent Results Show That BiondVax Pharmaceuticals's Universal Flu Vaccine Administered In A Trial 3 Years Ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 8/3/2015 7:00:33 AM